Identification | Back Directory | [Name]
Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate | [CAS]
147118-35-2 | [Synonyms]
B-8
Calcium side chain J6 rosuvastatin interMediates J-6 Rosuvastatin calcium side chain J6 -Methyl 3-((tert-butyldimethylsilyl) -5-oxo-6-(triphenylphosphoranylidene) Methyl (3R)-3-(tert-butyldimethylsilylox... J-6: METHYL(3R)-3-(TERT-BUTYLDIMETHYLSILYLOXY)-5- Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6- (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanoate Methyl(3R)-3-(tert-butyldimethylsiyloxy)-5-oxo-6-triphenylphosphoranylidenexanoate METHYL(3R)-(TERT-BUTYLDIMETHYLSILYLOXY)-5-OXO-6-TRIPHENYLPHOSPHORANYLIDENEHEXANOATE Methyl (3R)-3-(tert-butyldiMethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanate methyl-(3R)-3-[(terbutyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanoate Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate (R)-Methyl 3-((tert-butyldiMethylsilyl)oxy)-5-oxo-6-(triphenylphosphoranylidene)hexanoate Methyl (R)-3-((tert-butyldimethylsilyl)oxy)-5-oxo-6-(triphenyl-l5-phosphanylidene)hexanoate (3R)-3-(tert-butyldiMethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate Methyl ester METHYL (3R)-3-(TERT-BUTYLDIMETHYL SILYLOXY)-5-OXO-6-TRIPHENYL PHOSPHORANYLIDENE HEXANOATE (J6) (3R)-3-[[(tert-butyl)dimethylsilyl]oxy]-5-oxo-6-(triphenylphosphoranylidene)-hexanoic acid methyl ester Hexanoic acid,3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-5-oxo-6-(triphenylphosphoranylidene)-,Methyl ester, (3R)- | [EINECS(EC#)]
604-562-3 | [Molecular Formula]
C31H39O4PSi | [MDL Number]
MFCD09753068 | [MOL File]
147118-35-2.mol | [Molecular Weight]
534.7 |
Chemical Properties | Back Directory | [Boiling point ]
603.9±65.0 °C(Predicted) | [density ]
1.10±0.1 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,Store in freezer, under -20°C |
Hazard Information | Back Directory | [Uses]
Methyl (3R)-3-(tert-Butyldimethylsilanyloxy)-5-oxo-6-(triphenylphosphanylidene)hexanoate was used to preapre pyrimidinyl- and pyrrolylheptenoates with HMG-CoA reductase inhibitory activities. |
|
|